LSD, once a banned street drug, is being tested again as a depression treatment, and the latest large trials show real improvement after a single supervised dose.1BioSpace. Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial It is still experimental, though, and not something a doctor can prescribe for depression today.2AJMC. The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities It also seems to work differently from daily antidepressants: the aim is one guided experience rather than a pill every morning.
How Well LSD Worked in Depression Trials
The largest trial so far was a late-stage study in which people with depression got one 100-microgram dose of an LSD-based medicine called DT120 or a placebo.3Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences. A Single Dose of an LSD-Derived Therapy for Depression? Phase 3 Results Signal a Potential New Era in Psychedelic Medicine Depression scores dropped about 13 points with the drug and about 5 points with placebo, on a 60-point scale doctors use to rate depression.4Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences. A Single Dose of an LSD-Derived Therapy for Depression? Phase 3 Results Signal a Potential New Era in Psychedelic Medicine The drug therefore added roughly 8 points of improvement beyond what simply taking part in a trial produced.5BioSpace. Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial The improvement largely held at 12 weeks, at about 7 points beyond placebo, with no new safety concerns.6BioSpace. Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial These results were announced by the company developing the drug and have not yet gone through full independent review.
A gain of several points can mean small but real changes in daily life, like sleeping better or finding it easier to focus. An 8-point gain beyond placebo is larger than many standard antidepressants show in trials.
The placebo group improved too, since extra attention, hope and regular check-ins can lift mood on their own. That’s why the gap between drug and placebo is the number that counts.
That gap is also a group average. Some people improved far more than the average and some barely changed, and no trial can tell any one reader how they would respond. An average also doesn’t show how many people reached remission or response.
A separate trial in people with major depression compared a high dose of LSD with a low dose.7PubMed. Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial On doctors’ ratings, the high dose improved depression scores about three times as much as the low dose.8PubMed. Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial But once the researchers accounted for how depressed people were at the start, the difference was no longer clear enough to rule out chance.9PubMed. Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial The high dose looks better, but this smaller trial can’t prove it on its own.
Can You Get LSD Therapy for Depression Now
In the US, LSD is classed as Schedule I, meaning officially no accepted medical use, and that remains the main barrier to wider use.10AJMC. The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities It was outlawed in 1968, after the drug moved from research clinics to the streets.11BPS. Looking Back: A brief history of psychedelic psychiatry Earlier, from 1950 to 1965, around 40,000 patients had received some form of LSD therapy.12BPS. Looking Back: A brief history of psychedelic psychiatry
Doctors therefore can’t prescribe LSD for depression, and pharmacies can’t supply it. Research is still allowed, but it needs special licences and approvals, which is why access runs through formal trials.
The realistic way to receive LSD therapy right now is through a registered clinical trial. You can search clinical trial registries and ask your psychiatrist whether you might qualify. Expect screening for heart health, your current medicines, and personal or family history of psychosis. You may be randomly given a low dose or a placebo instead of a full dose. Sessions happen in a clinic with trained staff, followed by check-in visits.
Even a positive late-stage trial is a step toward approval, not approval itself. Regulators review the full trial data, not company announcements, and after approval, cost and insurance coverage are still open questions.
How Fast It Works and How Long It Lasts
Standard antidepressants usually take several weeks before people feel a clear difference. Psychedelic treatments, by contrast, have produced fast antidepressant effects that can outlast the drug itself.13PubMed. LSD: Mechanisms and relevance to the treatment of depression In healthy volunteers, LSD’s effects last longer than those of psilocybin, the active ingredient in magic mushrooms.14PubMed Central. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
The dose day itself is long. LSD’s effects last many hours, so a session fills most of a day, and the participant stays in the clinic with staff throughout. Emotions tend to be heightened rather than dulled, and people may feel intense feelings or memories. Most of the time is spent lying down or resting, often with music, while staff check in without directing the experience. Because the effects fade slowly, you can’t drive afterward and need someone to take you home.
In people with anxiety linked to a serious illness, improvements lasted 12 months.15BioSpace. Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial16PubMed. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects Still, trials followed people for months, not years, so no one yet knows how often doses would need repeating.
Why LSD May Help a Depressed Brain
Common antidepressants raise levels of mood chemicals such as serotonin over time.17PubMed. LSD: Mechanisms and relevance to the treatment of depression LSD takes a different route. It acts strongly on one serotonin receptor, called 2A, and also on glutamate, a chemical brain cells use to signal.18PubMed. Mechanisms of action and therapeutic perspectives of LSD: Current status Brain areas packed with these 2A receptors are the ones whose activity changes most on LSD.19PubMed. Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression
LSD also weakens activity in a brain network that is active when the mind dwells on itself.20PubMed Central. Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine It boosts communication between brain networks that normally work separately.21PubMed. Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution These changes track with the feeling that the sense of self is melting away.22(not provided). LSD Relaxes Structural Constraints on Brain Dynamics: A Connectome Harmonic MEG Study That may interrupt the repetitive negative thinking common in depression.
In lab experiments on brain cells, LSD strongly activated a receptor that helps cells grow new connections.23PubMed Central. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB This could explain why benefits outlast the drug, though it hasn’t been shown directly in people.
The experience itself may matter too. Some studies found that people who had stronger mystical-feeling experiences, such as a sense of unity or deep meaning, tended to improve more. Most trials saw it but not all, so it’s a pattern and not a rule. Frightening experiences may work against benefit, which is one reason preparation and a calm setting matter. It’s also unclear whether the experience causes the improvement or simply goes along with it.
What Happens in an LSD Therapy Session
The effects of psychedelics depend heavily on “set and setting”: your mindset and your surroundings.24PubMed Central. An international Delphi consensus for reporting of setting in psychedelic clinical trials So trials use calm rooms, music and therapists present throughout.
Treatment runs in three stages. Before the dose, preparation sessions let you meet the therapists, talk through your goals and learn what the experience may feel like. During the dose, you mostly rest in a calm room, and therapists stay nearby to reassure you if it becomes frightening. Afterward, follow-up conversations help you put what came up into words and think about how to use it in daily life.
Practitioners should be licensed and trained in psychotherapy.25Neuroethics. Mitigating Ethical Issues in Training for Psychedelic Therapy Trust between patient and therapist and clear professional boundaries are key ethical concerns.26PubMed Central. Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review Ask about credentials and supervision before any session. Warning signs include no medical screening, pressure to keep using or to pay for repeat sessions, and unclear boundaries while you are vulnerable.
Side Effects and Safety Risks
In research settings, single doses of 50 to 200 micrograms caused no major heart problems.27PubMed Central. Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function Heart rate, blood pressure and body temperature do rise moderately.28PubMed Central. Safety pharmacology of acute LSD administration in healthy subjects These rises are short-lived and larger at higher doses.29PubMed Central. Cardiovascular safety of psychedelic medicine: current status and future directions People with heart disease or high blood pressure need medical screening, and people with uncontrolled heart problems are usually excluded from trials.
About a third of people reported mild visual leftovers, like brighter colours or afterimages, 4 weeks after using a psychedelic.30PubMed Central. Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use Under 1% found them distressing, which is what’s needed for a diagnosis of HPPD (hallucinogen persisting perception disorder), a rare lasting visual disorder.31PubMed Central. Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use32PubMed Central. Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls
Genes can change the experience. About 1 in 14 people of European ancestry lack a working version of the liver enzyme CYP2D6. In these people LSD stays longer, and the trip lasts longer and feels more intense.33PubMed Central. Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis Other medicines can also alter how LSD is broken down.34PubMed. Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use Tell trial doctors about every medicine you take.
Addiction is not the main worry. LSD isn’t considered addictive, because people don’t develop compulsive craving or withdrawal from it, and repeated use quickly weakens the effect, so there’s little reason to take it daily. Problem use in studies appeared mostly in people combining several drugs. Treatment gives one or two supervised doses, not ongoing access.
Does Microdosing LSD Help Depression
Microdosing means taking tiny doses too small to cause a trip, repeated over weeks. That differs from the single full dose in the large trials, which is meant to produce a strong guided experience, so results from one approach can’t be applied to the other.
In one small study without a placebo group, depression scores fell by nearly 60% and stayed lower for six months.35PubMed. LSD microdosing in major depressive disorder: results from an open-label trial Another early trial found short-term mood gains in people with depression.36PubMed. LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial But without placebo groups, hope and expectation could explain much of this.37PubMed. LSD microdosing in major depressive disorder: results from an open-label trial Small studies like these suggest ideas to test, not answers.
Trying it on your own adds problems. Street LSD is hard to dose accurately, and it remains illegal. Never stop prescribed antidepressants without your doctor.
Why Some Results Remain Uncertain
Because LSD changes perception so strongly, trial participants usually know whether they received it.38PubMed Central. A Systematic Review of Study Design and Placebo Controls in Psychedelic Research Expecting to improve can itself boost results, making benefits look bigger.39JAMA Psychiatry. Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review The true size of the effect may be smaller than reported.
Beyond depression, LSD has also shown particular promise for anxiety linked to serious illness. Psilocybin has more depression data, and comparisons between psychedelics are still limited.